R.I. snags biotech firm

Michael Allio, chairman and acting CEO<br>of Mymetics.
Michael Allio, chairman and acting CEO
of Mymetics.
Mymetics Corp., a biotech company developing retrovirus therapies, has said goodbye to Maryland and hello to the Ocean State. The startup business, which was originally founded in France as HippoCampe in 2001, reinvented itself as Mymetics, a United States-based company with research and development facilities in Europe. In the same year, the company merged with…

Register to keep reading or subscribe today and receive unlimited access.
Register Now Already a Subscriber? Login now

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

No posts to display